tiprankstipranks
Intuitive Surgical (MX:ISRG)
:ISRG
Mexico Market

Intuitive Surgical (ISRG) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ISRG Analyst Ratings

Strong Buy
23Ratings
Strong Buy
20 Buy
3 Hold
0 Sell
Based on 23 analysts giving stock ratings to
Intuitive
Surgical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ISRG Stock 12 Month Forecast

Average Price Target

$8,337.42
▲(32.24% Upside)
Based on 23 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $8,337.42 with a high forecast of $11,576.23 and a low forecast of $6,607.74. The average price target represents a 32.24% change from the last price of $6,305.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6135":"$6,135","8856":"$8,856","11577":"$11,577","7495.5":"$7,495.5","10216.5":"$10,216.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11576.2256438,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8337.417403458,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6607.74339668,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6135,7495.5,8856,10216.5,11577],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6357.1,6758.571203369231,7160.042406738462,7561.513610107692,7962.984813476924,8364.456016846154,8765.927220215384,9167.398423584615,9568.869626953847,9970.340830323077,10371.812033692308,10773.28323706154,11174.75444043077,{"y":11576.2256438,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6357.1,6509.432107958308,6661.764215916615,6814.096323874923,6966.428431833231,7118.760539791539,7271.092647749846,7423.4247557081535,7575.756863666461,7728.088971624769,7880.421079583077,8032.753187541384,8185.085295499692,{"y":8337.417403458,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6357.1,6376.380261283077,6395.660522566154,6414.940783849231,6434.221045132308,6453.5013064153845,6472.781567698462,6492.061828981538,6511.342090264616,6530.622351547692,6549.90261283077,6569.182874113846,6588.4631353969235,{"y":6607.74339668,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8820,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8100,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9950,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10555,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10375,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8793,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8720,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8203.95,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7960,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7351,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6990,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6136.51,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6357.1,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$11,576Average Price Target$8,337Lowest Price Target$6,608
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG
$7,925.91
Buy
25.71%
Upside
Reiterated
09/07/26
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Tyra Bioscience (TYRA)
BMO Capital Analyst forecast on MX:ISRG
BMO Capital
BMO Capital
Buy
Reiterated
08/28/26
Analysts Offer Insights on Healthcare Companies: Impedimed Limited (Other OTC: IPDQF) and Intuitive Surgical (NASDAQ: ISRG)
Piper Sandler Analyst forecast on MX:ISRG
Piper Sandler
Piper Sandler
$7,942.81
Buy
25.98%
Upside
Reiterated
08/21/26
Intuitive Surgical (ISRG) Receives a Buy from Piper Sandler
Citi
$8,449.8
Buy
34.02%
Upside
Reiterated
08/13/26
Citi Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Oppenheimer Analyst forecast on MX:ISRG
Oppenheimer
Oppenheimer
$8,449.8
Buy
34.02%
Upside
Upgraded
08/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Legend Biotech (NASDAQ: LEGN) and Mineralys Therapeutics, Inc. (NASDAQ: MLYS)
Bank of America Securities Analyst forecast on MX:ISRG
Bank of America Securities
Bank of America Securities
$337.99$7,942.81
Buy
25.98%
Upside
Reiterated
08/11/26
Intuitive Surgical (ISRG) Gets a Buy from Bank of America Securities
Bernstein Analyst forecast on MX:ISRG
Bernstein
Bernstein
$11,576.23
Buy
83.60%
Upside
Reiterated
08/11/26
Intuitive Surgical: Buy Rating Reiterated as New GI Platform Progress Supports Growth; $685 Price Target Maintained
TD Cowen
$8,196.31
Buy
30.00%
Upside
Reiterated
08/03/26
Analyst Reiterates Buy on Intuitive Surgical, Seeing Johnson & Johnson’s Ottava as a Growth Catalyst Rather Than a Competitive Threat
HSBC
$6,607.74
Hold
4.80%
Upside
Downgraded
07/30/26
Intuitive Surgical downgraded to Hold from Buy at HSBCIntuitive Surgical downgraded to Hold from Buy at HSBC
UBS
$9,294.78$8,449.8
Buy
34.02%
Upside
Upgraded
07/28/26
Morgan Stanley upgrades Intuitive Surgical (ISRG) to a Buy
Wells Fargo Analyst forecast on MX:ISRG
Wells Fargo
Wells Fargo
$8,230.1
Buy
30.53%
Upside
Reiterated
07/23/26
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
J.P. Morgan Analyst forecast on MX:ISRG
J.P. Morgan
J.P. Morgan
$7,604.82
Buy
20.62%
Upside
Reiterated
07/21/26
J.P. Morgan Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
Mirae Asset Analyst forecast on MX:ISRG
Unknown Analyst
Mirae Asset
Not Ranked
Mirae Asset
Buy
Upgraded
07/21/26
Mirae Asset upgrades Intuitive Surgical (ISRG) to a Buy
Raymond James Analyst forecast on MX:ISRG
Raymond James
Raymond James
$9,751.07$8,162.51
Buy
29.46%
Upside
Reiterated
07/17/26
Intuitive Surgical price target lowered to $483 from $577 at Raymond JamesIntuitive Surgical price target lowered to $483 from $577 at Raymond James
Leerink Partners Analyst forecast on MX:ISRG
Leerink Partners
Leerink Partners
$9,683.47$7,672.42
Buy
21.69%
Upside
Reiterated
07/17/26
Intuitive Surgical price target lowered to $454 from $573 at LeerinkIntuitive Surgical price target lowered to $454 from $573 at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG
$7,925.91
Buy
25.71%
Upside
Reiterated
09/07/26
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Tyra Bioscience (TYRA)
BMO Capital Analyst forecast on MX:ISRG
BMO Capital
BMO Capital
Buy
Reiterated
08/28/26
Analysts Offer Insights on Healthcare Companies: Impedimed Limited (Other OTC: IPDQF) and Intuitive Surgical (NASDAQ: ISRG)
Piper Sandler Analyst forecast on MX:ISRG
Piper Sandler
Piper Sandler
$7,942.81
Buy
25.98%
Upside
Reiterated
08/21/26
Intuitive Surgical (ISRG) Receives a Buy from Piper Sandler
Citi
$8,449.8
Buy
34.02%
Upside
Reiterated
08/13/26
Citi Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Oppenheimer Analyst forecast on MX:ISRG
Oppenheimer
Oppenheimer
$8,449.8
Buy
34.02%
Upside
Upgraded
08/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Legend Biotech (NASDAQ: LEGN) and Mineralys Therapeutics, Inc. (NASDAQ: MLYS)
Bank of America Securities Analyst forecast on MX:ISRG
Bank of America Securities
Bank of America Securities
$337.99$7,942.81
Buy
25.98%
Upside
Reiterated
08/11/26
Intuitive Surgical (ISRG) Gets a Buy from Bank of America Securities
Bernstein Analyst forecast on MX:ISRG
Bernstein
Bernstein
$11,576.23
Buy
83.60%
Upside
Reiterated
08/11/26
Intuitive Surgical: Buy Rating Reiterated as New GI Platform Progress Supports Growth; $685 Price Target Maintained
TD Cowen
$8,196.31
Buy
30.00%
Upside
Reiterated
08/03/26
Analyst Reiterates Buy on Intuitive Surgical, Seeing Johnson & Johnson’s Ottava as a Growth Catalyst Rather Than a Competitive Threat
HSBC
$6,607.74
Hold
4.80%
Upside
Downgraded
07/30/26
Intuitive Surgical downgraded to Hold from Buy at HSBCIntuitive Surgical downgraded to Hold from Buy at HSBC
UBS
$9,294.78$8,449.8
Buy
34.02%
Upside
Upgraded
07/28/26
Morgan Stanley upgrades Intuitive Surgical (ISRG) to a Buy
Wells Fargo Analyst forecast on MX:ISRG
Wells Fargo
Wells Fargo
$8,230.1
Buy
30.53%
Upside
Reiterated
07/23/26
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
J.P. Morgan Analyst forecast on MX:ISRG
J.P. Morgan
J.P. Morgan
$7,604.82
Buy
20.62%
Upside
Reiterated
07/21/26
J.P. Morgan Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
Mirae Asset Analyst forecast on MX:ISRG
Unknown Analyst
Mirae Asset
Not Ranked
Mirae Asset
Buy
Upgraded
07/21/26
Mirae Asset upgrades Intuitive Surgical (ISRG) to a Buy
Raymond James Analyst forecast on MX:ISRG
Raymond James
Raymond James
$9,751.07$8,162.51
Buy
29.46%
Upside
Reiterated
07/17/26
Intuitive Surgical price target lowered to $483 from $577 at Raymond JamesIntuitive Surgical price target lowered to $483 from $577 at Raymond James
Leerink Partners Analyst forecast on MX:ISRG
Leerink Partners
Leerink Partners
$9,683.47$7,672.42
Buy
21.69%
Upside
Reiterated
07/17/26
Intuitive Surgical price target lowered to $454 from $573 at LeerinkIntuitive Surgical price target lowered to $454 from $573 at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
SNDXSyndax Pharmaceuticals
PTGXProtagonist Therapeutics
ONCBeOne Medicines
HITIHigh Tide
IRTCIrhythm Technologies
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months
Rick WiseStifel Nicolaus
Success Rate
22/29 ratings generated profit
76%
Average Return
+7.48%
Copying Rick Wise's trades and holding each position for 3 Months would result in 75.86% of your transactions generating a profit, with an average return of +7.48% per trade.
1 Year
Success Rate
19/27 ratings generated profit
70%
Average Return
+18.69%
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 70.37% of your transactions generating a profit, with an average return of +18.69% per trade.
2 Years
Success Rate
21/27 ratings generated profit
78%
Average Return
+37.15%
Copying Joanne Wuensch's trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +37.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ISRG Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
2
2
4
3
3
Buy
25
26
36
38
35
Hold
7
5
4
3
3
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
34
34
45
45
41
In the current month, ISRG has received 38 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ISRG average Analyst price target in the past 3 months is 8,337.42.
Each month's total comprises the sum of three months' worth of ratings.

ISRG Financial Forecast

ISRG Earnings Forecast

Next quarter’s earnings estimate for ISRG is $44.63 with a range of $42.74 to $46.63. The previous quarter’s EPS was $47.30. ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.
Next quarter’s earnings estimate for ISRG is $44.63 with a range of $42.74 to $46.63. The previous quarter’s EPS was $47.30. ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.

ISRG Sales Forecast

Next quarter’s sales forecast for ISRG is $49.12B with a range of $48.10B to $50.48B. The previous quarter’s sales results were $48.86B. ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.
Next quarter’s sales forecast for ISRG is $49.12B with a range of $48.10B to $50.48B. The previous quarter’s sales results were $48.86B. ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.

ISRG Stock Forecast FAQ

What is MX:ISRG’s average 12-month price target, according to analysts?
Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 8,337.42.
    What is MX:ISRG’s upside potential, based on the analysts’ average price target?
    Intuitive Surgical has 32.24% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Intuitive Surgical a Buy, Sell or Hold?
          Intuitive Surgical has a consensus rating of Strong Buy, which is based on 20 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Intuitive Surgical’s share price target?
            The average share price target for Intuitive Surgical is 8,337.42. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $11,576.23 ,and the lowest forecast is $6,607.74. The average share price target represents 32.24% Increase from the current price of $6,305.
              What do analysts say about Intuitive Surgical?
              Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.
                How can I buy shares of Intuitive Surgical?
                To buy shares of MX:ISRG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.